People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Other Health Care, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rallybio Holdings, LLC | — | Other Health Care | Series D+ | $157.8M | $69.6M | 2020 |
| Neuronetics, Inc. | — | Other Health Care | Series B | $118.7M | $332.3M | 2017 |
| IlluminOss Medical Inc | — | Other | Series B | $39.9M | $83.0M | 2014 |
| Qlaris Bio, Inc. | — | Biotechnology | Series B | $37.8M | $22.3M | 2019 |
Ron Hunt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron Hunt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ronald M. Hunt | 2 | 4 |
| Wende Hutton | 1 | 16 |
| Ketan Patel | 1 | 10 |
| Kush Parmar | 1 | 10 |
| Tim Shannon | 1 | 9 |
| Fouad Azzam | 1 | 8 |
| P. Sherrill Neff | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| Enrico Petrillo | 1 | 6 |
| Adrienne Graves | 1 | 6 |
| Brian Farley | 1 | 5 |
| Lee Wrubel | 1 | 5 |
| DAN SACHS | 1 | 4 |
| Daniel Omstead | 1 | 4 |
| Wilfred Jaeger | 1 | 4 |
| Bruce J. Shook | 1 | 3 |
| Gil Kliman | 1 | 3 |
| P. Sherill Neff | 1 | 3 |
| Michael Dale | 1 | 3 |
| Leslie Bottorff | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.